Fox Run Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-36,181
Closed -$252K 899
2025
Q3
$252K Buy
+36,181
New +$255K 0.04% 741
2025
Q2
Sell
-23,955
Closed -$153K 856
2025
Q1
$153K Sell
23,955
-63,618
-73% -$613K 0.02% 829
2024
Q4
$1.04M Buy
+87,573
New +$1.49M 0.19% 143
2024
Q3
Sell
-19,100
Closed -$456K 793
2024
Q2
$456K Buy
+19,100
New +$448K 0.09% 438
2023
Q1
Sell
-14,304
Closed -$169K 648
2022
Q4
$169K Buy
+14,304
New +$163K 0.07% 512

Other funds holding ASPN

Fox Run Management's ASPN Position: Q4 2025 in Review

Fox Run Management sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 36,181 shares — an estimated $252K sold.

Fox Run Management first reported a position in ASPN in Q4 2022 and held it in 5 quarters. The position peaked at $1.04M in Q4 2024. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Fox Run Management reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 36,181 Aspen Aerogels shares in Q4 2025, an estimated $252K.
  • Fox Run Management first reported a position in Aspen Aerogels in Q4 2022 and held it in 5 quarters.
  • Fox Run Management's Aspen Aerogels position peaked at $1.04M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.